Myxomas of the vocal fold are rare benign tumors often presenting with chronic dysphonia and less frequently with airway obstruction. The current consensus is that all laryngeal myxomas should be totally excised with clear margins to prevent recurrences. The recommendation for complete excision, however, has to be balanced with consideration of preserving vocal fold phonatory and sphincteric function. We report a case of vocal fold myxoma recurring twice after subtotal excision via two surgical approaches. This case illustrates a benign lesion with potential for recurrence and the need for a balanced treatment approach.
Introduction
Myxomas are benign mesenchymal neoplasms consisting of undifferentiated stellate cells in a loose mucoid stroma. 1 In the head and neck region, the most common sites of presentation are the mandible and maxilla, but there have also been reports in the nasal cavity, parotid, and oral mucosa. 2 Myxomas occurring in the laryngeal area are rare; our literature review identified only 11 previous cases, none of which recurred after initial excision. Of those 11 cases, only 7 were isolated to the vocal fold.
We describe the complicated case of a right vocal fold myxoma presenting as chronic hoarseness.
Case report
A 60-year-old man was referred to our department 12 months after a sudden onset of hoarseness unresponsive to proton-pump inhibitor therapy. The patient was an accountant who had stopped smoking in 1977, more than 30 years before presentation. Previous magnetic resonance imaging and computed tomography (CT) scans showed thickening of the right vallecula and vocal fold. Previous laryngovideostroboscopy (LVS) showed edema and erythema of the right vocal fold with normal movement and mucosal wave. Direct laryngoscopy with biopsy performed 6 months before the referral revealed only normal mucosa.
The patient was referred to our department for further evaluation because there had been no improvement on continued proton-pump inhibitor therapy. LVS suggested a mass within the right true vocal fold that disrupted normal vocal fold vibratory patterns. The patient had minimal to no vibration of the right true vocal fold. Glottic closure was complete, but vocal quality was raspy because of the absence of amplitude and mucosal wave of the right vocal fold. Progressive mass effect in the right vocal fold prompted a repeat CT scan, clearly delineating a submucosal mass. Repeat direct laryngoscopy revealed a deep submucosal mass that appeared to be adherent to the undersurface of the vocal ligament. Histologic review of a deep biopsy revealed a benign myxoma (figure 1).
Two months after the patient's initial referral, the mass was debulked via an external thyrotomy approach (figure 2). The bulk of the lesion was resected, leaving a small rim of tumor adherent to the overlying vocal ligament. The residual medial tumor was left in an attempt to preserve vocal function. The tumor was estimated to be approximately 10 mm at its greatest dimension.
Following surgery, the patient noted initial improvement of his voice that lasted for 3 to 4 months, with gradual deterioration over time. LVS was performed at that time, and the patient was found to have reduced amplitude of the right vocal fold although it was much greater than it was before surgery. A right vocal fold triamcinolone injection was administered 4 months postoperatively with mild improvement.
Over the next 2 years after the initial surgery, the patient noted a return of an intermittent but slowly progressive hoarseness, ultimately forcing him to stop working. Repeat LVS revealed a persistent erythematous right vocal fold with slow progression of mass effect and stiffness.
Twenty-seven months after the initial surgery, a microlaryngoscopy debulking procedure was performed. The tumor was again noted to be adherent to the submucosa and vocal ligament. A mucosal flap was elevated, and the tumor was removed in a piecemeal fashion because of adhesions of the mass to the surrounding tissue. Intraoperative examination of the mucosal flap suggested that the flap was intact, albeit with some fibrosis. Microscopic disease most likely still remained on the undersurface of the mucosal flap. Histologic examination confirmed recurrence of the laryngeal myxoma.
Immediately after the revision procedure, the patient once again noted an improvement in vocal quality. Unfortunately, over the first few months after the revision procedure, his voice function deteriorated. The deterioration was associated with apparent partial regrowth of the lesion. The patient developed a moderately harsh dysphonic voice and noted some odynophonia limiting his voice usage after approximately 1 hour of continuous speaking. However, over the next 26 months his voice stabilized, and he has had no aspiration or obstructive airway symptoms. During his last follow-up, more than 5 years after his initial presentation, the patient continued to be able to use his voice serviceably.
Discussion
In 1871, Virchow used the name myxoma to describe a tumor with a histiologic appearance resembling the mucinous substance of the umbilical cord. 3 In 1948, Stout reported a series of patients with myxomas and outlined diagnostic criteria: He described myxomas as nonmetastasizing, mesenchymal neoplasms composed of stellate cells in a loose mucoid stroma. 1 Myxomas are most common in the heart, soft tissue, and bone, but laryngeal myxomas are rare. There have Figure 2 . Intraoperatively, a submucous mass is seen inferior to the right vocal fold. 5 Including our case, 4 cases have been reported to have occurred at the supraglottis and 8 at the glottis. Ten cases presented as hoarseness or dysphonia and 2 cases presented as dyspnea. All but one case occurred in men; patients' ages ranged from 38 to 77 years (mean: 57.5). Supraglottic myxomas tended to be large, ranging from 5.6 to 6.5 cm, and most likely remained asymptomatic for a long time before diagnosis. Glottic myxomas measured from 4 to 25 mm and presumably caused early symptomatic hoarseness and dyspnea, leading to early detection and diagnosis.
Of all cases reported, one required an emergent tracheostomy for airway obstruction 1 year after the patient initially refused surgery for the polypoid lesion. 6 Excluding our case, no evidence of recurrent disease has been reported in follow-up (0 to 24 months). Nonetheless, myxomas in the head and neck region have been known to recur locally. 2 Previous authors have suggested taking out a rim of healthy tissue to ensure total excision of the myxoma. 5, 6 In the one previous case in which incomplete excision was performed, there was no evidence of macroscopic tumor recurrence during 18 months of follow-up. 5 At the time of our patient's initial surgery, we decided on an external approach in an effort to preserve vocal function because the lesion was deep to the vocal liga- ment; this decision was made despite the fact that all previously reported glottic lesions were removed with microlaryngoscopy. We decided to incompletely remove the myxoma, also in an effort to maintain vocal function. Serial postoperative LVS showed an increase in mass effect in our patient's vocal fold during a 27-month follow-up period. This finding, combined with the patient's worsening vocal quality, prompted a revision debulking procedure, this time performed via microlaryngoscopy. With suspected residual tumor, this patient will be followed closely and may eventually need more aggressive surgery.
Radiation therapy and a more radical surgical resection (i.e., hemilaryngectomy) were contemplated for this patient. Given the relatively benign histologic appearance of the lesion and its indolent clinical behavior, along with a lack of documented efficacy for radiation therapy, the patient elected against that treatment.
Treating the patient more aggressively with a "cancer" operation was repeatedly discussed, but it was decided that such a procedure would likely leave him with a comparable voice to what he currently possesses. Moreover, there was a paucity of obstructive symptoms which, if present, would have provoked a more radical approach. Also, the patient had no aspiration symptoms or dysphagia, which could result from a more aggressive surgical resection. For these reasons, he chose to be monitored without further treatment. This case illustrates the potential for partial recurrences and the need for balanced treatment decisions.
Conclusion
Complete excision of laryngeal myxomas with an adequate margin appears to be curative, but the attempt at complete excision must be balanced with an effort to preserve vocal function. A subtotal resection approach may prove most optimal in attempting to balance tumor control and preservation of function. This is particularly true for deep lesions involving the vocal ligament.
Preservation of the three primary purposes of laryngeal function-ventilation, vocalization, and prevention of aspiration-should affect one's surgical agenda. Cases in which subtotal excisions are performed necessitate routine follow-up to assess for recurrence status.
